Thanatophoric dysplasia in a dichorionic twin confirmed by genetic analysis at the early second trimester: A case report and literature review.
10.5468/ogs.2014.57.2.151
- Author:
Inji CHO
1
;
Jae Yoon SHIM
;
Gu Hwan KIM
;
Han Wook YOO
;
Eun Jung LEE
;
Hye Sung WON
;
Pil Ryang LEE
;
Ahm KIM
Author Information
1. Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. jyshim@amc.seoul.kr
- Publication Type:Case Report
- Keywords:
Fibroblast growth factor receptor 3 gene;
Selective termination;
Thanatophoric dysplasia;
Twins
- MeSH:
Amniocentesis;
Diagnosis;
DNA;
Female;
Fibroblast Growth Factor 3;
Humans;
Pregnancy;
Pregnancy Reduction, Multifetal;
Pregnancy Trimester, Second*;
Pregnancy, Twin;
Prenatal Diagnosis;
Prognosis;
Thanatophoric Dysplasia*;
Twins*;
Ultrasonography, Prenatal
- From:Obstetrics & Gynecology Science
2014;57(2):151-154
- CountryRepublic of Korea
- Language:English
-
Abstract:
Thanatophoric dysplasia (TD) is caused by mutation of the gene that encodes fibroblast growth factor 3 (FGFR3). Owing to the poor prognosis for TD, prenatal diagnosis is critical to optimal perinatal management. We report here a case of TD in twin pregnancy, which was prenatally diagnosed by DNA analysis following amniocentesis at 15 weeks, and was managed by selective fetal termination. Prenatal ultrasonography and molecular analysis to detect TD-specific mutations enable accurate diagnosis of FGFR3-related TD in utero and appropriate obstetrical management at early gestation during twin pregnancy.